CD177 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD177 monoclonal antibodies for research focused on understanding this important immune system protein. CD177 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD177, also known as neutrophil antigen 1 (NA1), is primarily expressed on the surface of neutrophils and plays a crucial role in the immune response, particularly in inflammation and infection. CD177's function in mediating neutrophil adhesion and migration makes it an important target for studying various pathological conditions, including autoimmune diseases and infections. Understanding the dynamics of CD177 can provide insights into the mechanisms of immune regulation and potential therapeutic interventions. CD177 monoclonal antibodies enable precise detection and characterization of neutrophil populations in various experimental settings. Researchers investigating neutrophil biology and inflammatory responses can utilize CD177 monoclonal antibodies to track cellular migration patterns and activation states. Santa Cruz Biotechnology monoclonal antibodies targeting CD177 contribute to advancing scientific understanding of immune system regulation and inflammatory disease mechanisms.